Respiratory syncytial virus infections in autologous blood and marrow transplant recipients with breast cancer: Combination therapy with aerosolized ribavirin and parenteral immunoglobulins

Bone Marrow Transplantation

Volumn 28, Issue 3, 2001, Pages 271-275

  Ghosh, S ^a   Champlin, R E ^a   Ueno, N T ^a   Anderlini, P ^a   Rolston, K ^a   Raad, I ^a   Kontoyiannis, D ^a   Jacobson, K ^a   Luna, M ^a   Tarrand, J ^a   Whimbey, E ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Autologous BMT; Breast cancer; Respiratory syncytial virus

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; CARMUSTINE; CISPLATIN; CYCLOPHOSPHAMIDE; ETOPOSIDE; IMMUNOGLOBULIN; RIBAVIRIN; STEROID; THIOTEPA; VIRUS ANTIBODY;

AEROSOL; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOTRANSPLANTATION; BLOOD AUTOTRANSFUSION; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; DRUG FORMULATION; HOSPITALIZATION; HUMAN; HUMAN CELL; MORTALITY; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY FAILURE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; TREATMENT OUTCOME; VIRUS INFECTION; VIRUS PNEUMONIA; WINTER;

AEROSOLS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ANTIVIRAL AGENTS; BONE MARROW TRANSPLANTATION; BREAST NEOPLASMS; DISEASE PROGRESSION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; PNEUMONIA, VIRAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RETROSPECTIVE STUDIES; RIBAVIRIN; SURVIVAL RATE; TRANSPLANTATION, AUTOLOGOUS;

EID: 17944376438     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703131     Document Type: Article

References (38)

1. Respiratory syncytial virus infections in immunocompromised adults
2. Respiratory virus infections in immunocompromised patients
3. Respiratory syncytial virus-induced acute lung injury in adult patients with bone marrow transplants: A clinical approach and review of the literature
4. Viral pneumonia in the immunocompromised adult with neoplastic disease: The role of common community respiratory viruses
5. An outbreak of respiratory syncytial virus in a bone marrow transplant center
6. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplants
7. Respiratory syncytial virus pneumonia among hospitalized adult patients with leukemia
8. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
9. Immunotherapy of respiratory syncytial virus pneumonia following bone marrow transplantation
10. Community respiratory virus infections in immunocompromised patients with cancer
11. Respiratory virus infections after marrow transplant: The Fred Hutchinson Cancer Research Center Experience
12. Respiratory virus infections in bone marrow transplant recipients: The European perspective
13. Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections
14. Phase I evaluation of a RSV-specific humanized monoclonal antibody (MEDI-493) after hematopoietic stem cell transplantation (HSCT)
15. Respiratory syncytial virus infection in adult BMT recipients: Effective therapy with short duration nebulised ribavirin
16. The outcome of 26 patients with respiratory syncytial virus infection following allogeneic stem cell transplantation
17. Respiratory syncytial virus immune globulin treatment of lower respiratory tract infection in pediatric patients undergoing bone marrow transplantation - A compassionate use experience
18. Respiratory syncytial virus infections in immunocompromised adults
19. Respiratory syncytial virus upper respiratory tract illnesses in adult blood and marrow transplant recipients: Combination therapy with aerosolized ribavirin and intravenous immunoglobulin
20. Conventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancer
21. Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast cancer
22. Epidemiology of acute lower respiratory diseases in children
23. Aerosolized ribavirin treatment of infants with respiratory syncytial virus infection: A randomized double-blind study
24. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infection in the cotton rat
25. Studies of passive immunotherapy for infections of respiratory syncytial virus in the respiratory tract of a primate model
26. Immunoglobulin administration and ribavirin therapy: Efficacy in respiratory syncytial virus infection of the cotton rat
27. Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children
28. Protective activity of a human respiratory syncytial virus immune globulin prepared from donors screened by microneutralization assay
29. Prophylactic administration of respiratory syncytial virus immune globulin to high-risk infants and young children
30. Immunoprophylaxis and immunotherapy of respiratory syncytial virus infected mice with respiratory syncytial virus specific immune serum
31. Immunoprophylaxis and immunotherapy are effective against respiratory syncytial virus infection in immunocompromised cotton rats
32. Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis
33. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants
34. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein
35. Effectiveness of RSVIG prophylaxis and therapy of respiratory of respiratory syncytial virus in an immunosuppressed animal model
36. Diagnosis of respiratory viruses in cancer and transplant patients
37. Infection control of nosocomial respiratory viral disease in the immunocompromised host
38. Nosocomial respiratory syncytial virus infections: Prevention and control in bone marrow transplant patients